(IBTK) iShares iBonds Dec 2030 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E5933 • Target Maturity
IBTK: U.S. Treasury Securities, Short-Term Paper, Cash, Cash Equivalents
The iShares iBonds Dec 2030 Term Treasury ETF (NASDAQ: IBTK) is designed to track the performance of U.S. Treasury securities maturing between January 1, 2030, and December 15, 2030. The fund invests in individual securities that align with the ICE 2030 Maturity U.S. Treasury Index, its underlying index. It may also hold short-term instruments like cash, cash equivalents, or money market funds managed by BFA or its affiliates to maintain liquidity.
As a target maturity ETF, IBTK is structured to gradually reduce its credit risk as it approaches its maturity date. This makes it a potential choice for investors seeking predictable returns tied to specific Treasury maturities. The funds AUM stands at $355.43 million, reflecting moderate scale in the fixed-income ETF space.
IBTK has shown stable trading activity, with an average 20-day volume of 115,304 shares. Its last price was $19.60, slightly above its 20-day SMA of $19.32 but closely aligned with its 50-day SMA of $19.20 and 200-day SMA of $19.21. The ATR of 0.07 indicates low volatility, consistent with the typical behavior of Treasury-focused ETFs.
3-Month Forecast - Market Outlook: Expect IBTK to maintain its price stability, with potential slight appreciation as it nears maturity. - Technical Outlook: The ETF is likely to trade within a narrow range, supported by its low ATR and alignment with its SMAs. - Fundamental Outlook: The funds AUM and focus on short-dated Treasuries position it for stability amid evolving interest rate environments.Additional Sources for IBTK ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBTK ETF Overview
| Market Cap in USD | 368m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2020-07-14 |
IBTK ETF Ratings
| Growth 5y | -9.08% |
| Fundamental | - |
| Dividend | 72.2% |
| Rel. Strength Industry | -1.94 |
| Analysts | - |
| Fair Price Momentum | 18.69 USD |
| Fair Price DCF | - |
IBTK Dividends
| Dividend Yield 12m | 3.61% |
| Yield on Cost 5y | 3.10% |
| Annual Growth 5y | 63.77% |
| Payout Consistency | 100.0% |
IBTK Growth Ratios
| Growth Correlation 3m | 72.2% |
| Growth Correlation 12m | 63.7% |
| Growth Correlation 5y | -41.6% |
| CAGR 5y | -3.57% |
| CAGR/Max DD 5y | -0.16 |
| Sharpe Ratio 12m | -0.26 |
| Alpha | 0.46 |
| Beta | 0.07 |
| Volatility | 4.51% |
| Current Volume | 84.8k |
| Average Volume 20d | 101.5k |
As of March 14, 2025, the stock is trading at USD 19.56 with a total of 84,761 shares traded.
Over the past week, the price has changed by +0.26%, over one month by +2.10%, over three months by +2.08% and over the past year by +4.94%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2030 is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -9.08 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBTK as of March 2025 is 18.69. This means that IBTK is currently overvalued and has a potential downside of -4.45%.
iShares iBonds Dec 2030 has no consensus analysts rating.
According to ValueRays Forecast Model, IBTK iShares iBonds Dec 2030 will be worth about 20.2 in March 2026. The stock is currently trading at 19.56. This means that the stock has a potential upside of +3.22%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 20.2 | 3.2% |